L-canavanine
| Internal ID | 8146c978-28e9-4ddb-89ee-970855796911 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Alpha amino acids > L-alpha-amino acids |
| IUPAC Name | (2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid |
| SMILES (Canonical) | C(CON=C(N)N)C(C(=O)O)N |
| SMILES (Isomeric) | C(CON=C(N)N)[C@@H](C(=O)O)N |
| InChI | InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-12-9-5(7)8/h3H,1-2,6H2,(H,10,11)(H4,7,8,9)/t3-/m0/s1 |
| InChI Key | FSBIGDSBMBYOPN-VKHMYHEASA-N |
| Popularity | 1,819 references in papers |
| Molecular Formula | C5H12N4O3 |
| Molecular Weight | 176.17 g/mol |
| Exact Mass | 176.09094026 g/mol |
| Topological Polar Surface Area (TPSA) | 137.00 Ų |
| XlogP | -4.80 |
| Atomic LogP (AlogP) | -2.01 |
| H-Bond Acceptor | 4 |
| H-Bond Donor | 4 |
| Rotatable Bonds | 5 |
| canavanine |
| 543-38-4 |
| Canavanin |
| 2-Amino-4-(guanidinooxy)butyric acid |
| O-((Aminoiminomethyl)amino)-L-homoserine |
| L-2-AMINO-4-(GUANIDINOOXY)BUTYRIC ACID |
| O-((Aminoiminomethyl)amino)homoserine |
| UNII-3HZV514J4B |
| (L)-CANAVANINE |
| (2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9095 | 90.95% |
| Caco-2 | - | 0.8580 | 85.80% |
| Blood Brain Barrier | + | 0.5500 | 55.00% |
| Human oral bioavailability | + | 0.8143 | 81.43% |
| Subcellular localzation | Mitochondria | 0.7832 | 78.32% |
| OATP2B1 inhibitior | - | 0.8488 | 84.88% |
| OATP1B1 inhibitior | + | 0.9708 | 97.08% |
| OATP1B3 inhibitior | + | 0.9390 | 93.90% |
| MATE1 inhibitior | - | 0.8200 | 82.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | - | 0.9450 | 94.50% |
| P-glycoprotein inhibitior | - | 0.9825 | 98.25% |
| P-glycoprotein substrate | - | 0.9697 | 96.97% |
| CYP3A4 substrate | - | 0.6921 | 69.21% |
| CYP2C9 substrate | - | 0.5960 | 59.60% |
| CYP2D6 substrate | - | 0.7636 | 76.36% |
| CYP3A4 inhibition | - | 0.8309 | 83.09% |
| CYP2C9 inhibition | - | 0.9071 | 90.71% |
| CYP2C19 inhibition | - | 0.9026 | 90.26% |
| CYP2D6 inhibition | - | 0.9230 | 92.30% |
| CYP1A2 inhibition | - | 0.9045 | 90.45% |
| CYP2C8 inhibition | - | 0.9733 | 97.33% |
| CYP inhibitory promiscuity | - | 0.9848 | 98.48% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.5020 | 50.20% |
| Eye corrosion | - | 0.9739 | 97.39% |
| Eye irritation | - | 0.8182 | 81.82% |
| Skin irritation | - | 0.7934 | 79.34% |
| Skin corrosion | - | 0.8923 | 89.23% |
| Ames mutagenesis | - | 0.5500 | 55.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.6219 | 62.19% |
| Micronuclear | + | 0.7300 | 73.00% |
| Hepatotoxicity | - | 0.6625 | 66.25% |
| skin sensitisation | - | 0.8449 | 84.49% |
| Respiratory toxicity | + | 0.6222 | 62.22% |
| Reproductive toxicity | + | 0.5444 | 54.44% |
| Mitochondrial toxicity | + | 0.6375 | 63.75% |
| Nephrotoxicity | - | 0.7477 | 74.77% |
| Acute Oral Toxicity (c) | III | 0.4821 | 48.21% |
| Estrogen receptor binding | - | 0.8378 | 83.78% |
| Androgen receptor binding | - | 0.8322 | 83.22% |
| Thyroid receptor binding | - | 0.8352 | 83.52% |
| Glucocorticoid receptor binding | - | 0.8104 | 81.04% |
| Aromatase binding | - | 0.8549 | 85.49% |
| PPAR gamma | - | 0.7205 | 72.05% |
| Honey bee toxicity | - | 0.9326 | 93.26% |
| Biodegradation | - | 0.5000 | 50.00% |
| Crustacea aquatic toxicity | - | 0.8900 | 89.00% |
| Fish aquatic toxicity | - | 0.9054 | 90.54% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
1995.3 nM |
Potency |
via CMAUP
|
| CHEMBL340 | P08684 | Cytochrome P450 3A4 |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
| CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
3981.1 nM 3981.1 nM |
Potency Potency |
via CMAUP
via CMAUP |
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.50% | 96.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 90.68% | 99.17% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 88.17% | 91.11% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 85.95% | 96.95% |
| CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 83.97% | 97.88% |
| CHEMBL2581 | P07339 | Cathepsin D | 83.92% | 98.95% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 83.85% | 92.29% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.84% | 94.45% |
| CHEMBL236 | P41143 | Delta opioid receptor | 83.16% | 99.35% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 81.61% | 90.20% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 80.15% | 90.71% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Achillea erba-rotta subsp. moschata |
| Canavalia ensiformis |
| Canavalia gladiata |
| Canavalia rosea |
| Colutea arborescens |
| Indigofera hirsuta |
| Medicago sativa |
| Sesbania herbacea |
| Trifolium repens |
| PubChem | 439202 |
| NPASS | NPC60672 |
| ChEMBL | CHEMBL443732 |
| LOTUS | LTS0093855 |
| wikiData | Q418408 |